Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Cahill Represents Lead Arrangers in $1.5 Billion Amended Credit Facilities for Catalent Pharma Solutions Inc.

Date: 05/17/19

Cahill represented the lead arrangers in connection with Catalent Pharma Solutions Inc.’s $950,000,000 Term B incremental credit facility and $550,000,000 revolving credit facility. Catalent Pharma Solutions Inc. is involved in technology and development for drugs, biologics and consumer health products. Proceeds from the incremental credit facility were used for the acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies, general corporate purposes and to refinance existing indebtedness.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com